Spyre Therapeutics
Price & Volume
Stats
See more52W Range | $10.91-$30.21 |
Market Cap | $2.3B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$177.4M |
Diluted EPS | -$1.31 |
News
See moreYahoo Finance • 12 days ago
Spyre Therapeutics (SYRE) Announces Positive Results for Phase 1 Study of SPY003
Yahoo Finance • 22 days ago
Spyre Therapeutics Announces Grants of Inducement Awards
Yahoo Finance • 25 days ago
Spyre Therapeutics Announces Positive Interim Phase 1 Results for SPY003, Its Novel, Half-Life Extended anti-IL-23 Antibody
Yahoo Finance • last month
Spyre Therapeutics Announces Poster Presentations at American College of Rheumatology (ACR) Convergence 2025
About
CEO | Dr. Cameron Turtle DPHIL, Ph.D. |
Address | 221 Crescent Street, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 95 |
